DoD Joint Warfighter Medical, Military Medical Research and Development Award | W81XWH 22 S JWMRP

Opportunity Information: Apply for W81XWH 22 S JWMRP

The DoD Joint Warfighter Medical, Military Medical Research and Development Award (MMRDA) is a Department of Defense funding opportunity under the U.S. Army Medical Research and Development Command (USAMRDC), administered by the U.S. Army Medical Research Acquisition Activity (USAMRAA). It is designed specifically to push forward prior, already-funded work rather than start brand-new projects from scratch. In practical terms, the program is looking for a logical continuation of earlier research or development efforts that align with the FY22 Joint Warfighter Medical Research Program (JWMRP) Focus Areas, with an emphasis on projects that are positioned to make real progress toward deployable medical products or healthcare solutions. The intended impact is broad: strengthening care and outcomes for military Service Members, Veterans, their families, other Military Health System beneficiaries, and, where applicable, the wider American public.

A key theme of this mechanism is acceleration and translation. The DoD is not simply funding exploratory science; it is prioritizing work that can augment and speed medical product development or the delivery of practical healthcare capabilities. The scope of allowable activities is wide across the medical R&D pipeline, ranging from preclinical studies to translational research and technology maturation, and continuing into human research. The announcement explicitly allows clinical studies, including correlative studies and early safety and efficacy testing for promising candidates, as well as development and evaluation of medical devices and enabling technologies. Importantly, it can also support later-stage clinical testing, including Phase 1, Phase 2, and Phase 3 clinical trials, which signals that the program is comfortable funding expensive, execution-heavy work when there is strong justification and readiness.

USAMRDC may award support through several different vehicles depending on what best fits the project and level of government involvement. These include assistance agreements such as grants and cooperative agreements, procurement contracts, and Other Transaction Agreements (OTAs). The inclusion of cooperative agreements suggests that some projects may involve substantial involvement from the government during performance (for example, coordinating milestones, facilitating access to DoD resources, or aligning deliverables with military medical needs). The opportunity is categorized as discretionary funding within Science and Technology and other Research and Development, and it is associated with CFDA number 12.420. The funding opportunity number is W81XWH 22 S JWMRP.

Eligibility is described as unrestricted, meaning the competition is open to many types of organizations (academia, nonprofits, small businesses, large businesses, and others), subject to any additional clarifications stated in the full announcement. However, this mechanism is invitation-based in the sense that invited applicants must submit full applications following the specific procedures in the funding opportunity announcement. The program anticipated making about four awards. The posted award ceiling is listed as 0, which usually indicates that a fixed cap is not stated in the summary and that applicants need to rely on the detailed program announcement for budget expectations, constraints, and appropriateness standards.

Collaboration with DoD organizations is encouraged when it strengthens the likelihood of success or speeds transition to military use. If an applicant plans to direct funds to a DoD laboratory or other DoD activity, the application is expected to document that portion of the budget using a specific template referenced as the "Suggested Collaborating DOD Military Facility Budget Format" (Attachment 15). This requirement signals that the program wants transparent accounting and clear planning when government labs are part of the execution team.

In short, this award mechanism targets projects that are already underway and have shown enough promise to justify follow-on investment, with the goal of moving them further along the path to tangible medical products, devices, vaccines, drugs, or clinically validated solutions that matter to operational military medicine and the broader healthcare landscape.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Joint Warfighter Medical, Military Medical Research and Development Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on Apr 07, 2022.
• Applicants must submit their applications by Jul 28, 2022. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 4 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 22 S JWMRP

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: